Total Positions
133
Quarter
2025 Q4
Top Holding
EWTX (7.9%)
Top 10 Concentration
40.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 133
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 7.86% | 5.92% |
#1
Prev: #1
|
3.1 | no change | no change |
P
S
|
15,518,492 | $385,091,379 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 6.61% | 5.40% |
#2
1
Prev: #3
|
2.6 | no change | no change |
P
S
|
301,200 | $323,693,616 | 2001 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 4.71% | 5.57% |
#3
1
Prev: #2
|
1.9 | -10,000 | -0.4% |
P
S
|
2,419,300 | $230,680,255 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SVA
SINOVAC BIOTECH...
|
Unknown | 3.77% | 4.33% |
#4
Prev: #4
|
1.5 | no change | no change |
P
S
|
2,718,735 | $184,466,170 | 2011 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 3.21% | 3.08% |
#5
3
Prev: #8
|
3.3 | 158,900 | 9.4% |
P
S
|
1,842,900 | $157,107,225 | 2011 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UPB
UPSTREAM BIO IN...
|
Healthcare | 3.16% | 2.52% |
#6
6
Prev: #12
|
1.3 | no change | no change |
P
S
|
5,693,589 | $154,580,941 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 3.04% | 3.02% |
#7
2
Prev: #9
|
1.2 | -23,800 | -8.3% |
P
S
|
263,400 | $149,179,224 | 2010 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 2.99% | 2.56% |
#8
3
Prev: #11
|
1.2 | -143,304 | -3.9% |
P
S
|
3,561,655 | $146,526,487 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 2.53% | 1.65% |
#9
8
Prev: #17
|
1.0 | -67,684 | -1.7% |
P
S
|
3,935,203 | $124,116,303 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARGX
ARGENX SE
|
Healthcare | 2.51% | 2.99% |
#10
Prev: #10
|
1.0 | -26,300 | -15.3% |
P
S
|
146,000 | $122,778,700 | 2017 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 2.50% | 3.83% |
#11
6
Prev: #5
|
1.0 | no change | no change |
P
S
|
7,959,538 | $122,576,885 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 2.34% | 3.23% |
#12
6
Prev: #6
|
1.0 | -12,800 | -4.2% |
P
S
|
288,800 | $114,841,320 | 2010 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYK
STRYKER CORPORA...
|
Healthcare | 2.33% | 3.12% |
#13
6
Prev: #7
|
1.0 | -34,200 | -9.5% |
P
S
|
325,000 | $114,227,750 | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPRY
ARS PHARMACEUTI...
|
Healthcare | 1.97% | 1.96% |
#14
1
Prev: #15
|
0.8 | no change | no change |
P
S
|
8,288,510 | $96,561,142 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 1.78% | 1.33% |
#15
6
Prev: #21
|
0.9 | -5,409,671 | -71.5% |
P
S
|
2,153,300 | $86,993,320 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 1.73% | 2.20% |
#16
3
Prev: #13
|
0.8 | -347,470 | -24.6% |
P
S
|
1,067,550 | $84,774,146 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAI
CARIS LIFE SCIE...
|
Healthcare | 1.72% | 2.16% |
#17
3
Prev: #14
|
2.7 | 81,153 | 2.7% |
P
S
|
3,116,011 | $84,069,977 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NTRA
NATERA INC
|
Healthcare | 1.71% | 1.62% |
#18
1
Prev: #19
|
0.7 | -63,500 | -14.8% |
P
S
|
365,800 | $83,801,122 | 2015 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 1.67% | 1.25% |
#19
6
Prev: #25
|
0.7 | no change | no change |
P
S
|
15,219,994 | $81,731,368 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 1.65% | 0.75% |
#20
20
Prev: #40
|
2.7 | 22,503 | 2.0% |
P
S
|
1,161,803 | $80,803,399 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DHR
DANAHER CORPORA...
|
Healthcare | 1.40% | 1.23% |
#21
7
Prev: #28
|
2.6 | 36,700 | 13.9% |
P
S
|
299,800 | $68,630,216 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 1.29% | 1.63% |
#22
4
Prev: #18
|
0.6 | -210,300 | -12.2% |
P
S
|
1,516,550 | $62,967,156 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APLS
APELLIS PHARMAC...
|
Healthcare | 1.25% | 1.24% |
#23
4
Prev: #27
|
2.5 | 106,500 | 4.6% |
P
S
|
2,429,868 | $61,038,284 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVBP
ARRIVENT BIOPHA...
|
Healthcare | 1.24% | 1.31% |
#24
2
Prev: #22
|
0.5 | no change | no change |
P
S
|
3,027,328 | $60,909,839 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CI
THE CIGNA GROUP
|
Healthcare | 1.15% | 1.10% |
#25
6
Prev: #31
|
2.5 | 42,200 | 25.9% |
P
S
|
205,000 | $56,422,150 | 2009 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SIBN
SI-BONE INC
|
Healthcare | 0.00% | 0.89% |
Sold All 😨
(Was: #37) |
0.3 | -2,578,979 | -100.0% |
CLOSED
|
— | $— | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SCPH
SCPHARMACEUTICA...
|
Unknown | 0.00% | 0.81% |
Sold All 😨
(Was: #38) |
0.3 | -6,059,528 | -100.0% |
CLOSED
|
— | $— | 2017 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ITGR
INTEGER HLDGS C...
|
Healthcare | 0.00% | 0.70% |
Sold All 😨
(Was: #42) |
0.3 | -290,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 0.59% |
Sold All 😨
(Was: #49) |
0.3 | -526,200 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABT
CALL
ABBOTT LABS
|
CALL Option | 0.00% | 0.47% |
Sold All 😨
(Was: #53) |
0.3 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2007 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
CALL
BOSTON SCIENTIF...
|
CALL Option | 0.00% | 0.46% |
Sold All 😨
(Was: #54) |
0.3 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2006 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PFE
CALL
PFIZER INC
|
CALL Option | 0.00% | 0.30% |
Sold All 😨
(Was: #67) |
0.3 | -500,000 | -100.0% |
CLOSED
|
— | $— | 2001 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AZN
CALL
ASTRAZENECA PLC
|
CALL Option | 0.00% | 0.27% |
Sold All 😨
(Was: #71) |
0.3 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2014 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 0.00% | 0.24% |
Sold All 😨
(Was: #74) |
0.3 | -750,600 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VSTM
VERASTEM INC
|
Healthcare | 0.00% | 0.18% |
Sold All 😨
(Was: #78) |
0.3 | -887,561 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MIST
MILESTONE PHARM...
|
Healthcare | 0.00% | 0.15% |
Sold All 😨
(Was: #82) |
0.3 | -3,221,828 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APLS
CALL
APELLIS PHARMAC...
|
CALL Option | 0.00% | 0.13% |
Sold All 😨
(Was: #84) |
0.3 | -250,000 | -100.0% |
CLOSED
|
— | $— | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BTSG
CALL
BRIGHTSPRING HE...
|
CALL Option | 0.00% | 0.10% |
Sold All 😨
(Was: #89) |
0.3 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRNX
PUT
CRINETICS PHARM...
|
PUT Option | 0.00% | 0.10% |
Sold All 😨
(Was: #91) |
0.3 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 0.00% | 0.09% |
Sold All 😨
(Was: #93) |
0.3 | -466,601 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
CALL
SCHOLAR ROCK HL...
|
CALL Option | 0.00% | 0.09% |
Sold All 😨
(Was: #94) |
0.3 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TGTX
CALL
TG THERAPEUTICS...
|
CALL Option | 0.00% | 0.08% |
Sold All 😨
(Was: #95) |
0.3 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CELCUITY INC
|
—
|
Bond/Debt | 0.00% | 0.06% |
Sold All 😨
(Was: #97) |
0.3 | -2,000,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
ATAI
ATAI LIFE SCIEN...
|
Healthcare | 0.00% | 0.04% |
Sold All 😨
(Was: #99) |
0.3 | -347,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRRO
KORRO BIO INC
|
Healthcare | 0.00% | 0.04% |
Sold All 😨
(Was: #100) |
0.3 | -32,400 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MURA
MURAL ONCOLOGY ...
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #101) |
0.3 | -588,800 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LYEL
LYELL IMMUNOPHA...
|
Healthcare | 0.00% | 0.02% |
Sold All 😨
(Was: #104) |
0.3 | -51,727 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KZR
KEZAR LIFE SCIE...
|
Healthcare | 0.00% | 0.02% |
Sold All 😨
(Was: #105) |
0.3 | -192,700 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XERS
XERIS BIOPHARMA...
|
Healthcare | 0.00% | 0.02% |
Sold All 😨
(Was: #106) |
0.3 | -80,420 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PASG
PASSAGE BIO INC
|
Healthcare | 0.00% | 0.01% |
Sold All 😨
(Was: #107) |
0.3 | -59,046 | -100.0% |
CLOSED
|
— | $— | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DHAI
DIH HLDG US INC
|
Healthcare | 0.00% | 0.01% |
Sold All 😨
(Was: #108) |
0.3 | -1,915,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 133 holdings